Diabetes Care

Papers
(The H4-Index of Diabetes Care is 85. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-04-01 to 2024-04-01.)
ArticleCitations
2. Classification and Diagnosis of Diabetes:Standards of Medical Care in Diabetes—20211635
2. Classification and Diagnosis of Diabetes:Standards of Medical Care in Diabetes—20221054
9. Pharmacologic Approaches to Glycemic Treatment: Standards of Medical Care in Diabetes—2021702
Social Determinants of Health and Diabetes: A Scientific Review602
2. Classification and Diagnosis of Diabetes: Standards of Care in Diabetes—2023548
6. Glycemic Targets: Standards of Medical Care in Diabetes—2021535
9. Pharmacologic Approaches to Glycemic Treatment: Standards of Medical Care in Diabetes—2022487
Management of Hyperglycemia in Type 2 Diabetes, 2022. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)437
Obesity and COVID-19 Severity in a Designated Hospital in Shenzhen, China425
6. Glycemic Targets: Standards of Medical Care in Diabetes—2022364
9. Pharmacologic Approaches to Glycemic Treatment: Standards of Care in Diabetes—2023341
10. Cardiovascular Disease and Risk Management: Standards of Medical Care in Diabetes—2021328
Outcomes in Patients With Hyperglycemia Affected by COVID-19: Can We Do More on Glycemic Control?313
Obesity Is a Risk Factor for Greater COVID-19 Severity296
Clinical Characteristics and Outcomes of Patients With Diabetes and COVID-19 in Association With Glucose-Lowering Medication295
Clinical Characteristics and Risk Factors for Mortality of COVID-19 Patients With Diabetes in Wuhan, China: A Two-Center, Retrospective Study287
New-Onset Type 1 Diabetes in Children During COVID-19: Multicenter Regional Findings in the U.K.280
10. Cardiovascular Disease and Risk Management: Standards of Medical Care in Diabetes—2022254
The Management of Type 1 Diabetes in Adults. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)239
Introduction: Standards of Medical Care in Diabetes—2022227
11. Microvascular Complications and Foot Care: Standards of Medical Care in Diabetes—2021214
5. Facilitating Behavior Change and Well-being to Improve Health Outcomes:Standards of Medical Care in Diabetes—2021206
Precision Medicine in Diabetes: A Consensus Report From the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)204
6. Glycemic Targets: Standards of Care in Diabetes—2023204
Sitagliptin Treatment at the Time of Hospitalization Was Associated With Reduced Mortality in Patients With Type 2 Diabetes and COVID-19: A Multicenter, Case-Control, Retrospective, Observational Stud191
COVID-19 Severity Is Tripled in the Diabetes Community: A Prospective Analysis of the Pandemic’s Impact in Type 1 and Type 2 Diabetes190
Diabetes Self-management Education and Support in Adults With Type 2 Diabetes: A Consensus Report of the American Diabetes Association, the Association of Diabetes Care & Education Specialists, th189
Effects of Novel Dual GIP and GLP-1 Receptor Agonist Tirzepatide on Biomarkers of Nonalcoholic Steatohepatitis in Patients With Type 2 Diabetes182
Advanced Liver Fibrosis Is Common in Patients With Type 2 Diabetes Followed in the Outpatient Setting: The Need for Systematic Screening172
10. Cardiovascular Disease and Risk Management: Standards of Care in Diabetes—2023161
COVID-19, Hyperglycemia, and New-Onset Diabetes160
5. Facilitating Behavior Change and Well-being to Improve Health Outcomes:Standards of Medical Care in Diabetes—2022159
Diabetes Management in Chronic Kidney Disease: A Consensus Report by the American Diabetes Association (ADA) and Kidney Disease: Improving Global Outcomes (KDIGO)158
Has COVID-19 Delayed the Diagnosis and Worsened the Presentation of Type 1 Diabetes in Children?158
14. Management of Diabetes in Pregnancy:Standards of Medical Care in Diabetes—2021158
Introduction: Standards of Medical Care in Diabetes—2021157
7. Diabetes Technology: Standards of Medical Care in Diabetes—2021156
Exploring Diseases/Traits and Blood Proteins Causally Related to Expression of ACE2, the Putative Receptor of SARS-CoV-2: A Mendelian Randomization Analysis Highlights Tentative Relevance of Diabetes-153
A Decade of Disparities in Diabetes Technology Use and HbA1c in Pediatric Type 1 Diabetes: A Transatlantic Comparison152
Effects of Continuous Glucose Monitoring on Metrics of Glycemic Control in Diabetes: A Systematic Review With Meta-analysis of Randomized Controlled Trials149
Effects of Cotadutide on Metabolic and Hepatic Parameters in Adults With Overweight or Obesity and Type 2 Diabetes: A 54-Week Randomized Phase 2b Study149
Consensus Report: Definition and Interpretation of Remission in Type 2 Diabetes147
11. Chronic Kidney Disease and Risk Management: Standards of Medical Care in Diabetes—2022146
7. Diabetes Technology: Standards of Medical Care in Diabetes—2022143
Improved Glycemic Outcomes With Medtronic MiniMed Advanced Hybrid Closed-Loop Delivery: Results From a Randomized Crossover Trial Comparing Automated Insulin Delivery With Predictive Low Glucose Suspe143
13. Children and Adolescents: Standards of Medical Care in Diabetes—2021141
Diabetes and COVID-19: Risks, Management, and Learnings From Other National Disasters138
Did the COVID-19 Lockdown Affect the Incidence of Pediatric Type 1 Diabetes in Germany?136
12. Older Adults:Standards of Medical Care in Diabetes—2021134
3. Prevention or Delay of Type 2 Diabetes:Standards of Medical Care in Diabetes—2021129
5. Facilitating Positive Health Behaviors and Well-being to Improve Health Outcomes:Standards of Care in Diabetes—2023127
Hyperglycemia at Hospital Admission Is Associated With Severity of the Prognosis in Patients Hospitalized for COVID-19: The Pisa COVID-19 Study125
Multicenter Trial of a Tubeless, On-Body Automated Insulin Delivery System With Customizable Glycemic Targets in Pediatric and Adult Participants With Type 1 Diabetes125
15. Diabetes Care in the Hospital: Standards of Medical Care in Diabetes—2021122
Worldwide Epidemiology of Diabetes-Related End-Stage Renal Disease, 2000–2015122
15. Management of Diabetes in Pregnancy:Standards of Medical Care in Diabetes—2022121
Time in Range in Relation to All-Cause and Cardiovascular Mortality in Patients With Type 2 Diabetes: A Prospective Cohort Study119
Type 2 Diabetes and COVID-19–Related Mortality in the Critical Care Setting: A National Cohort Study in England, March–July 2020119
8. Obesity and Weight Management for the Prevention and Treatment of Type 2 Diabetes:Standards of Medical Care in Diabetes—2022118
Intratrial Exposure to Vitamin D and New-Onset Diabetes Among Adults With Prediabetes: A Secondary Analysis From the Vitamin D and Type 2 Diabetes (D2d) Study114
7. Diabetes Technology: Standards of Care in Diabetes—2023112
Heart Failure: An Underappreciated Complication of Diabetes. A Consensus Report of the American Diabetes Association112
13. Older Adults: Standards of Medical Care in Diabetes—2022111
Metformin Use Is Associated With Slowed Cognitive Decline and Reduced Incident Dementia in Older Adults With Type 2 Diabetes: The Sydney Memory and Ageing Study111
16. Diabetes Care in the Hospital: Standards of Medical Care in Diabetes—2022110
Impact of Comorbidities and Glycemia at Admission and Dipeptidyl Peptidase 4 Inhibitors in Patients With Type 2 Diabetes With COVID-19: A Case Series From an Academic Hospital in Lombardy, Italy109
Type 1 Diabetes and COVID-19: Preliminary Findings From a Multicenter Surveillance Study in the U.S.107
Effect of Flash Glucose Monitoring on Glycemic Control, Hypoglycemia, Diabetes-Related Distress, and Resource Utilization in the Association of British Clinical Diabetologists (ABCD) Nationwide Audit107
Etiology, Epidemiology, and Disparities in the Burden of Diabetic Foot Ulcers104
High Prevalence of Advanced Liver Fibrosis Assessed by Transient Elastography Among U.S. Adults With Type 2 Diabetes101
Dapagliflozin Versus Placebo on Left Ventricular Remodeling in Patients With Diabetes and Heart Failure: The REFORM Trial101
4. Comprehensive Medical Evaluation and Assessment of Comorbidities: Standards of Medical Care in Diabetes—2021101
11. Chronic Kidney Disease and Risk Management: Standards of Care in Diabetes—2023100
14. Children and Adolescents: Standards of Medical Care in Diabetes—202297
Cost-effectiveness of Interventions to Manage Diabetes: Has the Evidence Changed Since 2008?97
8. Obesity Management for the Treatment of Type 2 Diabetes:Standards of Medical Care in Diabetes—202197
Association of Type 2 Diabetes With Cancer: A Meta-analysis With Bias Analysis for Unmeasured Confounding in 151 Cohorts Comprising 32 Million People94
Blood Glucose Control During Lockdown for COVID-19: CGM Metrics in Italian Adults With Type 1 Diabetes92
Cardiovascular Risk Reduction With Liraglutide: An Exploratory Mediation Analysis of the LEADER Trial91
Effects of Vitamin D Supplementation on Prevention of Type 2 Diabetes in Patients With Prediabetes: A Systematic Review and Meta-analysis89
Efficacy and Safety of Dulaglutide 3.0 mg and 4.5 mg Versus Dulaglutide 1.5 mg in Metformin-Treated Patients With Type 2 Diabetes in a Randomized Controlled Trial (AWARD-11)88
4. Comprehensive Medical Evaluation and Assessment of Comorbidities: Standards of Medical Care in Diabetes—202288
Association of Serum 25-Hydroxyvitamin D Concentrations With All-Cause and Cause-Specific Mortality Among Individuals With Diabetes87
Metabolomics and Type 2 Diabetes Risk: An Updated Systematic Review and Meta-analysis of Prospective Cohort Studies86
Adolescent Obesity and Early-Onset Type 2 Diabetes85
8. Obesity and Weight Management for the Prevention and Treatment of Type 2 Diabetes: Standards of Care in Diabetes—202385
0.069794893264771